These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion. Del Campo MT; González-Casaus ML; Aguado P; Bernad M; Carrera F; Martínez ME Osteoporos Int; 1999; 9(5):449-54. PubMed ID: 10550465 [TBL] [Abstract][Full Text] [Related]
4. Urinary galactosyl-hydroxylysine in postmenopausal osteoporotic women: A potential marker of bone fragility. Lo Cascio V; Bertoldo F; Gambaro G; Gasperi E; Furlan F; Colapietro F; Lo Cascio C; Campagnola M J Bone Miner Res; 1999 Aug; 14(8):1420-4. PubMed ID: 10457275 [TBL] [Abstract][Full Text] [Related]
5. Urinary output of hydroxylysine glycosides and pyridinium cross-links in detecting rat bone collagen turnover rate. Grazioli V; Alfano M; Stenico A; Casari E FEBS Lett; 1996 Jun; 388(2-3):134-8. PubMed ID: 8690072 [TBL] [Abstract][Full Text] [Related]
6. Ovariectomy in the rat induces a rapid increase in the urinary excretion of hydroxylysine glycosides and non-reducible crosslink residues. Casari E; Alfano M; Valente M; Clarke GD; Ferni G; Grazioli B Osteoporos Int; 1997; 7(6):539-43. PubMed ID: 9604049 [TBL] [Abstract][Full Text] [Related]
7. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070 [TBL] [Abstract][Full Text] [Related]
8. Analytical and clinical evaluation of the Bio-Rad HPLC kit for measurement of type I collagen cross links. Srivastava AK; Libanati C; Oberrauch W; Leenings J; Greenwald M; Baylink DJ J Bone Miner Metab; 2003; 21(3):134-44. PubMed ID: 12720047 [TBL] [Abstract][Full Text] [Related]
9. A comparative study on biochemical markers of bone collagen breakdown in post-menopausal women. Sirtori P; Sosio C; Polo RM; Tenni R; Rubinacci A Pharmacol Res; 1997 Sep; 36(3):229-35. PubMed ID: 9367668 [TBL] [Abstract][Full Text] [Related]
10. Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Taylor AK; Lueken SA; Libanati C; Baylink DJ Rheum Dis Clin North Am; 1994 Aug; 20(3):589-607. PubMed ID: 7984780 [TBL] [Abstract][Full Text] [Related]
11. Galactosylhydroxylysine and pyridinium cross links in monitoring the bone response to hormone replacement therapy. Marabini R; Sirtori P; Chionna R; Barzizza L; Rubinacci A J Endocrinol Invest; 1996 Mar; 19(3):154-8. PubMed ID: 8743280 [TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of the pyridinium cross-links of collagen in systemic lupus erythematosus. Kipen Y; Will R; Strauss BJ; Morand EF Clin Rheumatol; 1998; 17(4):271-6. PubMed ID: 9776107 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of biochemical markers of bone turnover and postmenopausal osteoporosis. Yilmaz N; Bayram M; Erbåğci AB; Kilinçer MS Clin Chem Lab Med; 1999 Feb; 37(2):137-43. PubMed ID: 10219502 [TBL] [Abstract][Full Text] [Related]
14. Collagen cross-links as a marker for subclinical atherosclerosis in postmenopausal women. Caglar GS; Kahyaoglu I; Ozdemir ED; Seker R; Demirtas S Menopause; 2014 Jan; 21(1):74-8. PubMed ID: 23736860 [TBL] [Abstract][Full Text] [Related]
15. Vitamin K in combination with other biochemical markers to diagnose osteoporosis. Heiss C; Hoesel LM; Wehr U; Keller T; Horas U; Meyer C; Rambeck W; Schnettler R Biomarkers; 2004; 9(6):479-88. PubMed ID: 15849068 [TBL] [Abstract][Full Text] [Related]
16. Markers of bone resorption--measurement in serum, plasma or urine? Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175 [TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate: advantage of free form of DPD over total DPD in predicting treatment efficacy. Kitatani K; Nakatsuka K; Naka H; Miki T; Morii H; Nishizawa Y J Bone Miner Metab; 2003; 21(4):217-24. PubMed ID: 12811626 [TBL] [Abstract][Full Text] [Related]
18. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study. Seibel MJ; Woitge H; Scheidt-Nave C; Leidig-Bruckner G; Duncan A; Nicol P; Ziegler R; Robins SP J Bone Miner Res; 1994 Sep; 9(9):1433-40. PubMed ID: 7817828 [TBL] [Abstract][Full Text] [Related]
19. The relationship between body composition and the urinary excretion of deoxypyridinoline and galactosyl-hydroxylysine in children and adolescents. Fricke O; Land C; Beccard R; Semler O; Stabrey A; Schoenau E J Bone Miner Metab; 2009; 27(6):689-97. PubMed ID: 19526303 [TBL] [Abstract][Full Text] [Related]
20. Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis. Nur E; Mairuhu W; Biemond BJ; van Zanten AP; Schnog JJ; Brandjes DP; Otten HM; Am J Hematol; 2010 Nov; 85(11):902-4. PubMed ID: 20882525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]